Abstract

Cutaneous leishmaniasis (CL) is a major public health problem worldwide and spreads to human via the bite of sand flies during blood meal. Following its inoculation, the promastigotes are immediately taken up by phagocytic cells and these leishmania-infected host cells produce proinflammatory cytokines that activate other immune cells and these infected host cells produce more cytokines and reactive nitrogen and oxygen species for efficient control of leishmania infection. Many experimental studies showed that resistance to infection with leishmania paraites is associated with the production of proinflammatory cytokines and activation of CD4+ Th1 response. On the other hand, vulnerability to this parasitic infection is correlated to production of T helper 2 cytokines that facilitate persistence of parasites and disease progression. In addition, some studies have also indicated that CD8+ T cells play a vital role in immune defense through cytokine production and their cytotoxic activity and excessive production of proinflammatory mediators promote amplified recruitment of cells. This could be correlated with excessive inflammatory reaction and ultimately resulted in tissue destruction and development of immunopathogenesis. Thus, there are contradictions regarding the role of immune responses in protection and immunopathogenesis of CL disease. Therefore, the aim of this paper was to review the role of host immune response in protection and its contribution to disease severity for CL infection. In order to obtain more meaningful data regarding the nature of immune response to leishmania, further in-depth studies focused on immune modulation should be conducted to develop better therapeutic strategies.

Highlights

  • IntroductionThe various clinical manifestations appeared to be determined predominantly by the host immune response and the parasite species [9,10,11,12]

  • Leishmaniasis is one of the most important vector-borne diseases caused by diverse intracellular protozoan parasites under the genus Leishmania

  • LCL is a localized form of Cutaneous leishmaniasis (CL) which is manifested with a protective immune response restricting the parasite to the inoculation site, and diffuse CL (DCL) is a nonulcerative disfiguring, disseminated lesion and resembles leprosy described by poor cellular immune response allowing uncontrolled spread of the parasite leishmania

Read more

Summary

Introduction

The various clinical manifestations appeared to be determined predominantly by the host immune response and the parasite species [9,10,11,12]. The promastigotes are able to persist in these phagocytic cells since they do have conceived machineries to evade the hosts’ immune response endeavors at controlling the parasite progress and disease establishment [15] and they transform into amastigote forms of the parasite and proliferate in macrophages and spread to other macrophages depending on various parasite and host factors. The objective of this seminar paper is to review the role of host immune response in protection and its contribution to disease severity during CL infection

Immune Response to Leishmania Infection
Immunopathogenesis of Cutaneous Leishmaniasis
Conclusions
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call